Copyright
        ©2014 Baishideng Publishing Group Inc.
    
    
        World J Gastroenterol. Dec 7, 2014; 20(45): 17037-17048
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17037
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17037
            Table 1 Performance of tumor necrosis factor receptor-associated protein 1 staining in distinguishing progressors from non-progressors
        
    | Using TRAP1 expression in different histologic grades as a biomarker (n) | Controls (n) | AUC value | Sensitivity at | |
| 90% specificity | 80% specificity | |||
| LGD (29) | Non-progressors (38) | 0.86 | 69% | 79% | 
| HGD (14) | Non-progressors (38) | 0.97 | 86% | 100% | 
| Cancer (17) | Non-progressors (38) | 0.87 | 82% | 88% | 
| Progressor rectal tissue (39) | Non-progressors (38) | 0.71 | 41% | 59% | 
| Highest TRAP1 in dysplasia (36) | Non-progressors (38) | 0.94 | 86% | 94% | 
| Highest overall TRAP1 (42) | Non-progressors (38) | 0.88 | 76% | 83% | 
            Table 2 Expression pattern of tumor necrosis factor receptor-associated protein 1 among different histologic grades within each progressor
        
    | Progressor case | Highest histologic grade present in the progressor | Rectum | LGD | HGD | CA | 
| 1 | LGD | - | - | NA | NA | 
| 2 | LGD | - | - | NA | NA | 
| 3 | LGD | - | - | NA | NA | 
| 4 | LGD | - | - | NA | NA | 
| 5 | LGD | + | + | NA | NA | 
| 6 | LGD | - | - | NA | NA | 
| 7 | LGD | + | + | NA | NA | 
| 8 | LGD | - | - | NA | NA | 
| 9 | LGD | - | - | NA | NA | 
| 10 | LGD | + | + | NA | NA | 
| 11 | LGD | + | + | NA | NA | 
| 12 | LGD | - | - | NA | NA | 
| 13 | LGD | + | + | NA | NA | 
| 14 | LGD | - | - | NA | NA | 
| 15 | LGD | - | - | NA | NA | 
| 16 | LGD | - | - | NA | NA | 
| 17 | LGD | + | + | NA | NA | 
| 18 | LGD | + | + | NA | NA | 
| 19 | LGD | + | + | NA | NA | 
| 20 | HGD | + | + | NA | NA | 
| 21 | HGD | - | - | NA | NA | 
| 22 | HGD | + | + | + | NA | 
| 23 | HGD | + | + | + | NA | 
| 24 | HGD | + | + | + | NA | 
| 25 | CA | - | - | + | + | 
| 26 | CA | + | + | + | + | 
| 27 | CA | + | + | + | + | 
| 28 | CA | NA | NA | NA | + | 
| 29 | CA | - | - | + | - | 
| 30 | CA | + | + | + | + | 
| 31 | CA | + | + | + | NA | 
| 32 | CA | - | - | NA | - | 
| 33 | CA | + | + | NA | + | 
| 34 | CA | NA | NA | + | + | 
| 35 | CA | NA | NA | NA | + | 
| 36 | CA | + | + | + | + | 
| 37 | CA | + | + | + | + | 
| 38 | CA | + | + | NA | + | 
| 39 | CA | + | + | + | + | 
| 40 | CA | + | + | NA | + | 
| 41 | CA | + | + | + | + | 
| 42 | CA | + | + | NA | + | 
- Citation: Chen R, Pan S, Lai K, Lai LA, Crispin DA, Bronner MP, Brentnall TA. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer. World J Gastroenterol 2014; 20(45): 17037-17048
- URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17037.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17037

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        